Cell-cell signaling through NOTCH regulates human embryonic stem cell proliferation

Stem Cells

Volumn 26, Issue 3, 2008, Pages 715-723

  Fox, Victoria ^a   Gokhale, Paul J ^a   Walsh, James R ^b   Matin, Maryam ^c   Jones, Mark ^a   Andrews, Peter W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b Axordia Ltd   (United Kingdom)

^c FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

Author keywords

Secretase; Apoptosis; Embryonal carcinoma; Embryonic stem cell; Human; NOTCH

Indexed keywords

NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; PROTEIN CBF1; REGULATOR PROTEIN; UNCLASSIFIED DRUG; ENZYME INHIBITOR; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; NOTCH RECEPTOR;

ARTICLE; CARCINOMA CELL; CELL COMMUNICATION; CELL PROLIFERATION; EMBRYO; EMBRYONIC STEM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; APOPTOSIS; CELL CULTURE; CELL DIFFERENTIATION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; EMBRYONAL CARCINOMA; METABOLISM; MOUSE; PATHOLOGY; PLURIPOTENT STEM CELL; PROTEIN PROCESSING; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, SURFACE; APOPTOSIS; CARCINOMA, EMBRYONAL; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; EMBRYONIC STEM CELLS; ENZYME INHIBITORS; HUMANS; MICE; PLURIPOTENT STEM CELLS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 42549084012     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0368     Document Type: Article

References (46)

1. Daheron L, Opitz SL, Zaehres H et al. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. STEM CELLS 2004;22:770-778.
2. Williams BP, Daniels GL, Pym B et al. Biochemical and genetic analysis of the OKa blood group antigen. Immunogenetics 1988;27:322-329.
3. Smith AG, Heath JK, Donaldson DD et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 1988;336:688-690.
4. Ying QL, Nichols J, Chambers I et al. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 2003;115:281-292.
5. Andrews PW. From teratocarcinomas to embryonic stem cells. Philos Trans R Soc Lond B Biol Sci 2002;357:405-417.
6. Andrews PW, Damjanov I, Berends J et al. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7). Lab Invest 1994;71:243-251.
7. Draper JS, Pigott C, Thomson JA et al. Surface antigens of human embryonic stem cells: Changes upon differentiation in culture. J Anat 2002;200:249-258.
8. Andrews PW, Bronson DL, Benham F et al. A comparative study of eight cell lines derived from human testicular teratocarcinoma. Int J Cancer 1980;26:269-280.
9. Andrews PW, Goodfellow PN, Shevinsky LH et al. Cell-surface antigens of a clonal human embryonal carcinoma cell line: Morphological and antigenic differentiation in culture. Int J Cancer 1982;29:523-531.
10. Shevinsky LH, Knowles BB, Damjanov I et al. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 1982;30:697-705.
11. Kannagi R, Levery SB, Ishigami F et al. New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. J Biol Chem 1983;258:8934-8942.
12. Damjanov I, Horvat B, Gibas Z. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT. Lab Invest 1993;68:220-232.
13. Xu RH, Chen X, Li DS et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol 2002;20:1261-1264.
14. Harun R, Ruban L, Matin M et al. Cytotrophoblast stem cell lines derived from human embryonic stem cells and their capacity to mimic invasive implantation events. Hum Reprod 2006;21:1349-1358.
15. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000;24:372-376.
16. Andrews PW. Human embryonal carcinoma cells in culture do not synthesize fibronectin until they differentiate. Int J Cancer 1982;30:567-571.
17. Amit M, Carpenter MK, Inokuma MS et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 2000;227:271-278.
18. Enver T, Soneji S, Joshi C et al. Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum Mol Genet 2005;14:3129-3140.
19. Hurlbut GD, Kankel MW, Lake RJ et al. Crossing paths with Notch in the hyper-network. Curr Opin Cell Biol 2007;19:166-175.
20. Chiba S. Notch signaling in stem cell systems. STEM CELLS 2006;24:2437-2447.
21. Bray SJ. Notch signalling: A simple pathway becomes complex. Nat Rev Mol Cell Biol 2006;7:678-689.
22. Walsh J, Andrews PW. Expression of Wnt and Notch pathway genes in a pluripotent human embryonal carcinoma cell line and embryonic stem cell. APMIS 2003;111:197-210; discussion 210-191.
23. Adamah DJ, Gokhale PJ, Eastwood DJ et al. Dysfunction of the mitotic: meiotic switch as a potential cause of neoplastic conversion of primordial germ cells. Int J Androl 2006;29:219-227.
24. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
25. Andrews PW. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev Biol 1984;103:285-293.
26. Zagouras P, Stifani S, Blaumueller CM et al. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc Natl Acad Sci U S A 1995;92:6414-6418.
27. Hamaguchi Y, Yamamoto Y, Iwanari H et al. Biochemical and immunological characterization of the DNA binding protein (RBP-J kappa) to mouse J kappa recombination signal sequence. J Biochem 1992;112:314-320.
28. Andrews PW, Banting G, Damjanov I et al. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma 1984;3:347-361.
29. Shearman MS, Beher D, Clarke EE et al. L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid beta-protein precursor gamma-secretase activity. Biochemistry 2000;39:8698-8704.
30. De Strooper B, Annaert W, Cupers P et al. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 1999;398:518-522.
31. Giesberts AN, Duran C, Morton IN et al. The expression and function of cadherin-mediated cell-to-cell adhesion in human embryonal carcinoma cells. Mech Dev 1999;83:115-125.
32. Androutsellis-Theotokis A, Leker RR, Soldner F et al. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 2006;442:823-826.
33. Li J, Wang G, Wang C et al. MEK/ERK signaling contributes to the maintenance of human embryonic stem cell self-renewal. Differentiation 2007;75:299-307.
34. Armstrong L, Hughes O, Yung S et al. The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet 2006;15:1894-1913.
35. Noggle SA, Weiler D, Condie BG. Notch signaling is inactive but inducible in human embryonic stem cells. STEM CELLS 2006;24:1646-1653.
36. Lowell S, Benchoua A, Heavey B et al. Notch promotes neural lineage entry by pluripotent embryonic stem cells. PLoS Biol 2006;4:e121.
37. Roy M, Pear WS, Aster JC. The multifaceted role of Notch in cancer. Curr Opin Genet Dev 2007;17:52-59.
38. Miele L, Osborne B. Arbiter of differentiation and death: Notch signaling meets apoptosis. J Cell Physiol 1999;181:393-409.
39. Spierings DC, de Vries EG, Vellenga E et al. The attractive Achilles heel of germ cell tumours: An inherent sensitivity to apoptosis-inducing stimuli. J Pathol 2003;200:137-148.
40. Andrews PW, Matin MM, Bahrami AR et al. Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: Opposite sides of the same coin. Biochem Soc Trans 2005;33:1526-1530.
41. Talora C, Campese AF, Bellavia D et al. Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma. EMBO Rep 2003;4:1067-1072.
42. Shin HM, Minter LM, Cho OH et al. Notch1 augments NF-kappaB activity by facilitating its nuclear retention. EMBO J 2006;25:129-138.
43. Cheng P, Zlobin A, Volgina V et al. Notch-1 regulates NF-kappaB activity in hemopoietic progenitor cells. J Immunol 2001;167:4458-4467.
44. Vacca A, Felli MP, Palermo R et al. Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia. EMBO J 2006;25:1000-1008.
45. Herszfeld D, Wolvetang E, Langton-Bunker E et al. CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nat Biotechnol 2006;24:351-357.
46. Oka C, Nakano T, Wakeham A et al. Disruption of the mouse RBP-J kappa gene results in early embryonic death. Development 1995;121:3291-3301.